Phospholipid derivative
View Patent ↗A phospholipid derivative represented by the following formula (I) wherein R 1 CO and R 2 CO independently represent an acyl group; R 3 represents hydrogen atom, or a hydrocarbon group; symbol “a” represents an integer of 0 to 4; symbol “b” represents 0 or 1, provided that when a is 0, b is 0; X represents hydrogen atom, an alkali metal atom, an ammonium, or an organic ammonium; A 1 O and A 3 O represent an oxyalkylene group containing oxyethylene group, wherein the ratio of the oxyethylene group to the oxyalkylene group in A 1 O and A 3 O is 0.5 or larger in terms of a weight ratio; A 2 O represents an oxyalkylene group; symbols “m” and “q” represent an average molar number of added oxyalkylene groups; and symbol “n” represent an average molar number of added oxyalkylene groups; provided that m, n and q satisfy the following conditions: 5≦m≦600, 1≦n≦45, 0≦q≦200, 10≦m+n+q≦600, 0.04≦n/(m+n+q), and q/(m+n+q)≦0.8, which can thicken the water shell of liposome surface by suppressing the spreading of the polyalkylene oxide structure on the surface and thus increase stability of the liposome
1. A phospholipid derivative represented by the following formula (I):
wherein R 1 CO and R 2 CO independently represent an acyl group having 8 to 22 carbon atoms; R 3 represents hydrogen atom, or a hydrocarbon group having 1 to 4 carbon atoms; symbol “a” represents an integer of 0 to 4; symbol “b” represents 0 or 1, provided that when a is 0, b is 0; X represents hydrogen atom, an alkali metal atom, an ammonium, or an organic ammonium; A 1 O and A 3 O independently represent an oxyalkylene group containing oxyethylene group and having 2 to 4 carbon atoms, wherein the ratio of the oxyethylene group to the oxyalkylene group having 2 to 4 carbon atoms in A 1 O and A 3 O is 0.5 or larger in terms of a weight ratio; A 2 O represents an oxyalkylene group having 3 or 4 carbon atoms; symbols “m” and “q” independently represent an average molar number of added oxyalkylene groups having 2 to 4 carbon atoms; and symbol “n” represent an average molar number of added oxyalkylene groups having 3 or 4 carbon atoms; provided that m, n and q satisfy the following conditions:
5≦ m≦ 600, 1≦ n≦ 45, 0≦ q≦ 200, 10≦ m+n+q≦ 600, 0.04≦ n /( m+n+q ), and q /( m+n+q )≦0.8.
2. A phospholipid derivative represented by the following formula (II):
wherein R 1 CO and R 2 CO independently represent an acyl group having 8 to 22 carbon atoms; R 3 represents hydrogen atom, or a hydrocarbon group having 1 to 4 carbon atoms; symbol “a” represents an integer of 0 to 4; symbol “b” represents 0 or 1, provided that when a is 0, b is 0; X represents hydrogen atom, an alkali metal atom, an ammonium, or an organic ammonium; EO represents oxyethylene group; AO represents an oxyalkylene group having 3 or 4 carbon atoms; {(EO)s/(AO)t} represents a group consisting of randomly bonded oxyethylene groups and oxyalkylene groups having 3 or 4 carbon atoms, wherein the ratio of the oxyethylene groups to the oxyalkylene groups having 2 to 4 carbon atoms in {(EO)s/(AO)t} is 0.5 to 0.95 in terms of a weight ratio; symbol “s” represents an average molar number of added oxyethylene groups; and symbol “t” represent an average molar number of added oxyalkylene groups having 3 or 4 carbon atoms; provided that s and t satisfy the following conditions:
5≦ s≦ 500, 0≦ t≦ 100, and 6≦( s+t )≦500.
3. The phospholipid derivative according to claim 1 , wherein A 1 O and A 3 O are oxyethylene groups.
4. The phospholipid derivative according to claim 1 , wherein A 1 O and A 3 O are oxyethylene groups, and A 2 O is oxypropylene group.
5. The phospholipid derivative according to claim 1 , wherein A 1 O is oxyethylene group, A 2 O is oxypropylene group, and q is 0.
6. The phospholipid derivative according to claim 2 , wherein AO is oxypropylene group, and the ratio of oxyethylene groups to oxyethylene groups and oxypropylene groups is 0.60 to 0.95.
7. A lipid membrane structure comprising the phospholipid derivative according to claim 1 .
8. A pharmaceutical composition containing the lipid membrane structure according to claim 7 and a medicament.
9. The pharmaceutical composition according to claim 8 , wherein the medicament is an antitumor agent.
10. A surfactant comprising the phospholipid derivative according to claim 1 .
11. A lipid membrane structure comprising the phospholipid derivative according to claim 2 .
12. A lipid membrane structure comprising the phospholipid derivative according to claim 3 .
13. A lipid membrane structure comprising the phospholipid derivative according to claim 4 .
14. A lipid membrane structure comprising the phospholipid derivative according to claim 5 .
15. A lipid membrane structure comprising the phospholipid derivative according to claim 6 .
16. A surfactant comprising the phospholipid derivative according to claim 2 .
17. A surfactant comprising the phospholipid derivative according to claim 3 .
18. A surfactant comprising the phospholipid derivative according to claim 4 .
19. A surfactant comprising the phospholipid derivative according to claim 5 .
20. A surfactant comprising the phospholipid derivative according to claim 6 .